These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24140674)

  • 21. The influence of post-infarct heart failure and high fat diet on the expression of apelin APJ and vasopressin V1a and V1b receptors.
    Czarzasta K; Wojno O; Zera T; Puchalska L; Dobruch J; Cudnoch-Jedrzejewska A
    Neuropeptides; 2019 Dec; 78():101975. PubMed ID: 31645268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts.
    Regitz-Zagrosek V; Friedel N; Heymann A; Bauer P; Neuss M; Rolfs A; Steffen C; Hildebrandt A; Hetzer R; Fleck E
    Circulation; 1995 Mar; 91(5):1461-71. PubMed ID: 7867188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxytocin and vasopressin 1a receptor gene expression in the cycling or pregnant human uterus.
    Helmer H; Hackl T; Schneeberger C; Knöfler M; Behrens O; Kaider A; Husslein P
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1572-8. PubMed ID: 9855599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertension.
    Burrell LM; Risvanis J; Dean RG; Patel SK; Velkoska E; Johnston CI
    J Am Soc Hypertens; 2013; 7(1):3-13. PubMed ID: 23246465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conivaptan: a selective vasopressin antagonist for the treatment of heart failure.
    Schwarz ER; Sanghi P
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):17-23. PubMed ID: 16375624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Mune T; Murase H; Yamakita N; Fukuda T; Murayama M; Miura A; Suwa T; Hanafusa J; Daido H; Morita H; Yasuda K
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5706-13. PubMed ID: 12466375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myocardial expression and distribution of calcineurin in normal and failing human ventricular myocardium].
    Wang JC; Zhao Y; Wang CX; Liu W; Shao JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Apr; 36(4):332-6. PubMed ID: 19100011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.
    Li X; Chan TO; Myers V; Chowdhury I; Zhang XQ; Song J; Zhang J; Andrel J; Funakoshi H; Robbins J; Koch WJ; Hyslop T; Cheung JY; Feldman AM
    Circulation; 2011 Aug; 124(5):572-81. PubMed ID: 21747049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyponatremia in heart failure: concluding remarks.
    Chatterjee K
    Heart Fail Rev; 2009 Jun; 14(2):87-8. PubMed ID: 18758942
    [No Abstract]   [Full Text] [Related]  

  • 31. Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist.
    Kolkhof P; Pook E; Pavkovic M; Kretschmer A; Buchmüller A; Tinel H; Delbeck M; Mondritzki T; Wasnaire P; Dinh W; Truebel H; Hüser J; Schmeck C
    J Cardiovasc Pharmacol; 2019 Jul; 74(1):44-52. PubMed ID: 31274842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated expression of cardiac ankyrin repeat protein in human failing hearts due to arrhythmogenic right ventricular cardiomyopathy.
    Wei YJ; Cui CJ; Huang YX; Zhang XL; Zhang H; Hu SS
    Eur J Heart Fail; 2009 Jun; 11(6):559-66. PubMed ID: 19359327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
    Bristow MR; Minobe WA; Raynolds MV; Port JD; Rasmussen R; Ray PE; Feldman AM
    J Clin Invest; 1993 Dec; 92(6):2737-45. PubMed ID: 8254027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy.
    Medina E; Sucharov CC; Nelson P; Miyamoto SD; Stauffer BL
    J Pediatr; 2017 Mar; 182():184-189.e1. PubMed ID: 27908653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure.
    Zolk O; Quattek J; Sitzler G; Schrader T; Nickenig G; Schnabel P; Shimada K; Takahashi M; Böhm M
    Circulation; 1999 Apr; 99(16):2118-23. PubMed ID: 10217651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of inotropic agents in acute and chronic congestive heart failure.
    Sanders MR; Kostis JB; Frishman WH
    Med Clin North Am; 1989 Mar; 73(2):283-314. PubMed ID: 2645478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen costs of left ventricular contractility for dobutamine and Ca(2+) in normal rat hearts and the cost for dobutamine in Ca(2+) overload-induced failing hearts.
    Tabayashi N; Abe T; Kobayashi S; Yoshikawa Y; Sakata S; Takenaka C; Misawa H; Taniguchi S; Takaki M
    Jpn J Physiol; 2002 Apr; 52(2):163-71. PubMed ID: 12139774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure.
    Damås JK; Eiken HG; Oie E; Bjerkeli V; Yndestad A; Ueland T; Tonnessen T; Geiran OR; Aass H; Simonsen S; Christensen G; Froland SS; Attramadal H; Gullestad L; Aukrust P
    Cardiovasc Res; 2000 Sep; 47(4):778-87. PubMed ID: 10974226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance.
    Hurbin A; Orcel H; Alonso G; Moos F; Rabié A
    Endocrinology; 2002 Feb; 143(2):456-66. PubMed ID: 11796498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.